Paper20501673
S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration.
Bergelin N and 4 others. Endocrinology, 2010. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration. Papers, record 20501673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20501673
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Movement | Major topic |
| Mitogen-Activated Protein Kinase 1 | Major topic |
| Mitogen-Activated Protein Kinase 3 | Major topic |
| Protein Kinase C-alpha | Major topic |
| Receptors, Lysosphingolipid | Major topic |
| Thyroid Neoplasms | Major topic |
| Vascular Endothelial Growth Factor Receptor-2 | Major topic |
| Blotting, Western | |
| Cell Line, Tumor | |
| Humans | |
| Immunohistochemistry | |
| Immunoprecipitation | |
| Lysophospholipids | |
| Phosphorylation | |
| Protein Binding | |
| Signal Transduction | |
| Sphingosine | |
| Vascular Endothelial Growth Factor A |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938850 | Lipid Mediators as Therapeutic Targets in Prostate Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938850 | PubMed |
| 42450239 | The Sphingolipid Balance and Endothelial Dysfunction in Lysosomal Storage Diseases: Shared Mechanisms in Gaucher, Niemann-Pick and Fabry Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450239 | PubMed |
| 39596225 | PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596225 | PubMed |
| 34155535 | Stromal interaction molecule 1 (STIM1) knock down attenuates invasion and proliferation and enhances the expression of thyroid-specific proteins in human follicular thyroid cancer cells. | Cell Mol Life Sci | 2021 | https://conductscience.org/library/papers/34155535 | PubMed |
| 32944615 | S1PR1 and VEGFR2 - a synergy that promotes tumor angiogenesis? | Mol Cell Oncol | 2020 | https://conductscience.org/library/papers/32944615 | PubMed |
| 32585303 | Post-translational modifications of S1PR1 and endothelial barrier regulation. | Biochim Biophys Acta Mol Cell Biol Lipids | 2020 | https://conductscience.org/library/papers/32585303 | PubMed |
| 31825830 | Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling. | Cell Rep | 2019 | https://conductscience.org/library/papers/31825830 | PubMed |
| 31383843 | O-cyclic phytosphingosine-1-phosphate stimulates HIF1α-dependent glycolytic reprogramming to enhance the therapeutic potential of mesenchymal stem cells. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31383843 | PubMed |
| 31115798 | S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy. | Mol Diagn Ther | 2019 | https://conductscience.org/library/papers/31115798 | PubMed |
| 30956148 | Complex Formation between VEGFR2 and the β2-Adrenoceptor. | Cell Chem Biol | 2019 | https://conductscience.org/library/papers/30956148 | PubMed |
| 30171498 | Perfused 3D angiogenic sprouting in a high-throughput in vitro platform. | Angiogenesis | 2019 | https://conductscience.org/library/papers/30171498 | PubMed |
| 29734379 | Sphingosine 1-phosphate attenuates MMP2 and MMP9 in human anaplastic thyroid cancer C643 cells: Importance of S1P2. | PLoS One | 2018 | https://conductscience.org/library/papers/29734379 | PubMed |
| 28565866 | Inhibition of PKCα reduces the ability of migration of kidney cancer cells but has no impact on cell apoptosis. | Exp Ther Med | 2017 | https://conductscience.org/library/papers/28565866 | PubMed |
| 28241498 | Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian Cells. | Molecules | 2017 | https://conductscience.org/library/papers/28241498 | PubMed |
| 27330306 | Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/27330306 | PubMed |
| 25978354 | Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway. | PLoS One | 2015 | https://conductscience.org/library/papers/25978354 | PubMed |
| 25971967 | Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphingolipid and VEGF Receptor Expression: IMPLICATIONS FOR THYROID CANCER CELL MIGRATION AND PROLIFERATION. | J Biol Chem | 2015 | https://conductscience.org/library/papers/25971967 | PubMed |
| 25698653 | Peptide Lv augments L-type voltage-gated calcium channels through vascular endothelial growth factor receptor 2 (VEGFR2) signaling. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/25698653 | PubMed |
| 25588843 | S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness. | J Cell Sci | 2015 | https://conductscience.org/library/papers/25588843 | PubMed |
| 25356505 | Cell-surface receptors transactivation mediated by g protein-coupled receptors. | Int J Mol Sci | 2014 | https://conductscience.org/library/papers/25356505 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KDR | 3791 | PubTator's text mining | https://conductscience.org/library/genes/3791 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MAPK3 | 5595 | PubTator's text mining | https://conductscience.org/library/genes/5595 | NCBI Gene |
| PRKACA | 5566 | PubTator's text mining | https://conductscience.org/library/genes/5566 | NCBI Gene |
| PRKCA | 5578 | PubTator's text mining | https://conductscience.org/library/genes/5578 | NCBI Gene |
| S1PR1 | 1901 | PubTator's text mining | https://conductscience.org/library/genes/1901 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
| VEGFC | 7424 | PubTator's text mining | https://conductscience.org/library/genes/7424 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20501673
GET https://conductscience.org/api/papers/v1/20501673/cited_by?page=2